These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10434232)
1. Systemic absorption of clindamycin after intravaginal administration of clindamycin phosphate ovule or cream. Borin MT; Ryan KK; Hopkins NK J Clin Pharmacol; 1999 Aug; 39(8):805-10. PubMed ID: 10434232 [TBL] [Abstract][Full Text] [Related]
2. An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations. Levinson RS; Mitan SJ; Steinmetz JI; Gattermeir DJ; Schumacher RJ; Joffrion JL Clin Ther; 2005 Dec; 27(12):1894-900. PubMed ID: 16507375 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. Sobel J; Peipert JF; McGregor JA; Livengood C; Martin M; Robbins J; Wajszczuk CP Infect Dis Obstet Gynecol; 2001; 9(1):9-15. PubMed ID: 11368263 [TBL] [Abstract][Full Text] [Related]
5. Systemic absorption of clindamycin following intravaginal application of clindamycin phosphate 1% cream. Borin MT J Clin Pharmacol; 1990 Jan; 30(1):33-8. PubMed ID: 2303578 [TBL] [Abstract][Full Text] [Related]
6. Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis. McCormack WM; Covino JM; Thomason JL; Eschenbach DA; Mou S; Kapernick P; McGregor J; Rein MF; Hillier SL Sex Transm Dis; 2001 Oct; 28(10):569-75. PubMed ID: 11689755 [TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis. Minozzi M; Gerli S; Di Renzo GC; Papaleo E; Ferrari A Eur Rev Med Pharmacol Sci; 2008; 12(1):59-65. PubMed ID: 18401974 [TBL] [Abstract][Full Text] [Related]
8. A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal cream. Bhamra RK; Margolis MB; Liu JH; Hendy CH; Jenkins RG; DiLiberti CE Menopause; 2011 Apr; 18(4):393-9. PubMed ID: 21107298 [TBL] [Abstract][Full Text] [Related]
9. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261 [TBL] [Abstract][Full Text] [Related]
10. Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days. Upmalis DH; Cone FL; Lamia CA; Reisman H; Rodriguez-Gomez G; Gilderman L; Bradley L J Womens Health Gend Based Med; 2000 May; 9(4):421-9. PubMed ID: 10868615 [TBL] [Abstract][Full Text] [Related]
11. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Hillier S; Krohn MA; Watts DH; Wolner-Hanssen P; Eschenbach D Obstet Gynecol; 1990 Sep; 76(3 Pt 1):407-13. PubMed ID: 2381617 [TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile toxin-induced colitis after use of clindamycin phosphate vaginal cream. Meadowcroft AM; Diaz PR; Latham GS Ann Pharmacother; 1998 Mar; 32(3):309-11. PubMed ID: 9533061 [TBL] [Abstract][Full Text] [Related]
13. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs. Batzias GC; Delis GA; Athanasiou LV Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847 [TBL] [Abstract][Full Text] [Related]
14. A new approach for the treatment of bacterial vaginosis: use of polyhexamethylene biguanide. A prospective, randomized study. Gerli S; Rossetti D; Di Renzo GC Eur Rev Med Pharmacol Sci; 2003; 7(5):127-30. PubMed ID: 15214587 [TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics study of two different clindamycin capsule formulations: a randomized, two-period, two-sequence, two-way crossover clinical trial in healthy volunteers. Sanki UK; Mandal BK; Chandrakala V Arzneimittelforschung; 2011; 61(9):538-43. PubMed ID: 22029232 [TBL] [Abstract][Full Text] [Related]
16. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers. He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976 [TBL] [Abstract][Full Text] [Related]
17. Changes in vaginal flora after 2% clindamycin vaginal cream in women at high risk of preterm birth. Lamont DF BJOG; 2003 Aug; 110(8):788-9. PubMed ID: 12892701 [No Abstract] [Full Text] [Related]
18. [Streptococcus group B and pregnancy: the therapeutic role of topical intravaginal clindamycin]. Danti L; Ravelli V; Lojacono A; Tanzi P; Comberti E; Foresti I; Bondio M; Gastaldi A Minerva Ginecol; 1997 May; 49(5):235-40. PubMed ID: 9304087 [TBL] [Abstract][Full Text] [Related]